ArticleTheranostics2022

Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival.

Kaili Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.